CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.

Bonifant, Challice L

CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy 09 2016 - 1615-26 p. digital

Publication Type: Journal Article

1525-0024

10.1038/mt.2016.116 doi


Animals
Antigens, CD20--genetics
CD3 Complex--genetics
Cell Line, Tumor
Cell Survival--drug effects
Complement System Proteins--immunology
Cytokines--metabolism
Cytotoxicity, Immunologic
Disease Models, Animal
Genes, Transgenic, Suicide--genetics
Genetic Vectors--genetics
Hematopoietic Stem Cells--immunology
Humans
Immunotherapy--methods
Interleukin-3 Receptor alpha Subunit--genetics
Leukemia, Myeloid, Acute--genetics
Mice
Retroviridae--genetics
Rituximab--pharmacology
T-Lymphocytes--immunology
Transduction, Genetic
Xenograft Model Antitumor Assays